Free Trial
→ Satellite Images Spot Potential $10 Trillion Discovery (From Altimetry) (Ad)tc pixel Free SNY Stock Alerts

Sanofi (SNY) News Today

Sanofi logo
$43.18 -0.59 (-1.35%)
Closing price 05/7/2026 04:00 PM Eastern
Extended Trading
$43.35 +0.17 (+0.39%)
As of 05/7/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SNY Latest News

Truist Financial Corp Sells 37,780 Shares of Sanofi $SNY
May 7 at 5:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-truist-financial-corp-sells-37780-shares-of-sanofi-sny-2026-05-07/
Sanofi asks to pull diabetes drug out of FDA voucher program, STAT News reports
May 6 at 2:38 PM  |  reuters.comhttps://www.reuters.com/legal/litigation/sanofi-asks-pull-diabetes-drug-out-fda-voucher-program-stat-news-reports-2026-05-06/
Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1
May 6 at 12:42 PM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/sanofi-supports-alphadetect-to-accelerate-detection-of-alpha-1-302764446.html
Sanofi $SNY Shares Sold by UBS Group AG
May 6 at 8:15 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-sanofi-sny-shares-sold-by-ubs-group-ag-2026-05-06/
Sanofi (NASDAQ:SNY) Sets New 1-Year Low - Should You Sell?
May 5 at 5:39 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sanofi-nasdaqsny-sets-new-1-year-low-should-you-sell-2026-05-05/
Sanofi (NASDAQ:SNY) Shares Gap Down Following Analyst Downgrade
May 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sanofi-nasdaqsny-shares-gap-down-following-analyst-downgrade-2026-05-04/
M&T Bank Corp Sells 402,012 Shares of Sanofi $SNY
May 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-mt-bank-corp-sells-402012-shares-of-sanofi-sny-2026-05-03/
Morgan Stanley Downgrades Sanofi (NASDAQ:SNY) to Equal Weight
May 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/morgan-stanley-downgrades-sanofi-nasdaqsny-to-equal-weight-2026-05-01/
Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
April 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/29/3284073/0/en/press-release-annual-general-meeting-of-april-29-2026-bel%c3%a9n-garijo-appointed-as-director-and-chief-executive-officer-of-sanofi.html
Sanofi (NASDAQ:SNY) Upgraded at Argus
April 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sanofi-nasdaqsny-upgraded-at-argus-2026-04-29/
Erste Group Bank Issues Positive Outlook for Sanofi Earnings
April 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/erste-group-bank-issues-positive-outlook-for-sanofi-earnings-2026-04-29/
Three stacked coin columns of increasing height alongside a rising green arrow illustrate financial growth.
Giants Costco, Sanofi, and SAP Raise Dividends by Over 10% (SNY)
Dividends are on the rise at Costco, Sanofi, and SAP, three of the world's largest companies with market capitalizations above $100 billion.
April 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/stock-ideas/giants-costco-sanofi-and-sap-raise-dividends-by-over-10/
Sanofi (SNY) Announces Financial Results for Q1 2026
April 27, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/sanofi-sny-announces-financial-results-055427727.html
Managed Asset Portfolios LLC Cuts Stock Position in Sanofi $SNY
April 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-managed-asset-portfolios-llc-cuts-stock-position-in-sanofi-sny-2026-04-27/
Weekly Buzz: Sanofi, Regeneron Pharmaceuticals Get FDA Nod; It's A No For AbbVie, Grace Therapeutics; Eli Lilly Acquires Kelonia
April 25, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-04/68298723-weekly-buzz-sanofi-regeneron-pharmaceuticals-get-fda-nod-it-s-a-no-for-abbvie-grace-therapeutics-eli-lilly-acquires-kelonia-020.htm
Sanofi (NASDAQ:SNY) Given Consensus Recommendation of "Hold" by Analysts
April 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sanofi-nasdaqsny-given-consensus-recommendation-of-hold-by-analysts-2026-04-25/
3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery
April 25, 2026  |  fool.comhttps://www.fool.com/investing/2026/04/25/3-healthcare-stocks-that-pay-you-a-dividend-while/
Press Release: Sanofi successfully prices 2.3 billion of bond issue
April 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/24/3281028/0/en/press-release-sanofi-successfully-prices-2-3-billion-of-bond-issue.html
Sanofi, Arrowhead, Novartis among winners of EU recommendations this week
April 24, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4579462-sanofi-arrowhead-novartis-win-chmp-backing
Press Release: Sanofi's Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
April 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/24/3280641/0/en/press-release-sanofi-s-cenrifki-tolebrutinib-recommended-for-eu-approval-by-the-chmp-to-treat-secondary-progressive-multiple-sclerosis-without-relapses.html
Sanofi Q1 Earnings Call Highlights
April 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sanofi-q1-earnings-call-highlights-2026-04-23/
Sanofi and Regeneron’s Dupixent becomes first biologic for kids under 12 with CSU
April 23, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4578407-sanofi-and-regenerons-dupixent-becomes-first-biologic-for-kids-under-12-with-csu
Sanofi 2026 Q1 - Results - Earnings Call Presentation
April 23, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4893326-sanofi-2026-q1-results-earnings-call-presentation
Sanofi Posts Higher Sales Amid Leadership Transition
April 23, 2026  |  wsj.comhttps://www.wsj.com/business/earnings/sanofi-posts-higher-sales-amid-leadership-transition-7a7e2f3f
Sanofi's first quarter earnings edges past estimates ahead of CEO change
April 23, 2026  |  reuters.comhttps://www.reuters.com/legal/litigation/sanofis-first-quarter-earnings-edges-past-estimates-ahead-ceo-change-2026-04-23/
Press Release: Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
April 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/22/3279472/0/en/press-release-sanofi-and-regeneron-s-dupixent-approved-in-the-us-as-the-first-biologic-medicine-for-young-children-with-uncontrolled-chronic-spontaneous-urticaria.html
Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children
April 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/22/3278650/0/en/press-release-sanofi-s-tzield-approved-in-the-us-to-delay-the-onset-of-stage-3-type-1-diabetes-in-young-children.html
Press Release: Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US
April 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/22/3278646/0/en/press-release-sanofi-provides-update-on-the-regulatory-submission-for-sarclisa-subcutaneous-in-the-us.html
Sanofi SA Sponsored ADR
April 20, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/SNY
Farther Finance Advisors LLC Purchases 25,098 Shares of Sanofi $SNY
April 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-farther-finance-advisors-llc-purchases-25098-shares-of-sanofi-sny-2026-04-20/
Benson Investment Management Company Inc. Purchases Shares of 111,920 Sanofi $SNY
April 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-benson-investment-management-company-inc-purchases-shares-of-111920-sanofi-sny-2026-04-18/
Assetmark Inc. Purchases 86,496 Shares of Sanofi $SNY
April 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-assetmark-inc-purchases-86496-shares-of-sanofi-sny-2026-04-16/
Sanofi (SNY) to Release Earnings on Thursday
April 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sanofi-sny-to-release-earnings-on-thursday-2026-04-16/
Sanofi (NASDAQ:SNY) Announces Dividend Increase - $2.42 Per Share
April 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/sanofi-nasdaqsny-announces-dividend-increase-242-per-share-2026-04-15/
Press Release: Sanofi and Regeneron's Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
April 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/13/3272182/0/en/press-release-sanofi-and-regeneron-s-dupixent-approved-in-the-eu-as-the-first-targeted-medicine-to-treat-young-children-with-chronic-spontaneous-urticaria.html
Sanofi $SNY Shares Purchased by Willis Investment Counsel
April 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-sanofi-sny-shares-purchased-by-willis-investment-counsel-2026-04-09/
Erste Group Bank Has Positive View of Sanofi FY2026 Earnings
April 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/erste-group-bank-has-positive-view-of-sanofi-fy2026-earnings-2026-04-09/
Press Release: Sanofi's lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
April 7, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/04/07/3268809/0/en/press-release-sanofi-s-lunsekimig-met-primary-and-key-secondary-endpoints-in-phase-2-respiratory-studies-in-asthma-and-crswnp.html
Sanofi (SNYNF) Gets a Hold from Kepler Capital
April 4, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/SNY/pressreleases/1104237/sanofi-snynf-gets-a-hold-from-kepler-capital/
Press Release: Sanofi's Rezurock approved in the EU to treat chronic graft-vs-host disease
March 31, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/31/3265145/0/en/press-release-sanofi-s-rezurock-approved-in-the-eu-to-treat-chronic-graft-vs-host-disease.html
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
March 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/28/3264184/0/en/press-release-aad-new-results-from-sanofi-s-amlitelimab-phase-3-studies-in-atopic-dermatitis-presented-in-late-breaking-research-session.html
EU regulator backs Sanofi's injectable version of blood cancer drug
March 27, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/eu-regulator-backs-sanofis-injectable-version-blood-cancer-drug-2026-03-27/
Bipartisan US senators reportedly reach breakthrough to cap insulin prices at $35 – SNY, LLY, NVO stocks gain pre-market
March 25, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/bipartisan-us-senators-reportedly-reach-breakthrough-to-cap-insulin-prices-at-35-sny-lly-nvo-stocks-gain-pre-market/ar-AA1ZndAk
FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports
March 25, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/fda-grants-breakthrough-therapy-designation-to-venglustat-in-the-us-sanofi-sny-reports-1723911/
Sanofi: Availability of the Q1 2026 aide-mémoire
March 24, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-03/68017994-sanofi-availability-of-the-q1-2026-aide-memoire-399.htm
Press release: Availability of the Q1 2026 aide-mémoire
March 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/24/3260956/0/en/press-release-availability-of-the-q1-2026-aide-m%c3%a9moire.html
Press Release: Sanofi and Regeneron's Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
March 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/24/3260948/0/en/press-release-sanofi-and-regeneron-s-dupixent-approved-in-japan-as-the-first-targeted-medicine-to-treat-adults-with-bullous-pemphigoid.html
Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment
March 23, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/kali-therapeutics-signs-deal-with-sanofi-develop-autoimmune-treatment-2026-03-23/
Sanofi launches innovation and operation centre in China
March 20, 2026  |  reuters.comhttps://www.reuters.com/business/healthcare-pharmaceuticals/sanofi-launches-innovation-operation-centre-china-2026-03-20/
Sanofi’s venglustat granted US breakthrough therapy status for type 3 Gaucher disease
March 18, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/sanofi-s-venglustat-granted-us-breakthrough-therapy-status-for-type-3-gaucher-disease/ar-AA1YSyRI
Get Sanofi News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SNY Media Mentions By Week

SNY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SNY
News Sentiment
▼
0.18

0.50
▲
Average
Medical
News Sentiment

SNY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SNY Articles
This Week
▼
9

9
▲
SNY Articles
Average Week

Get the Latest News and Ratings for SNY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Sanofi and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
Headlines Tools

This page (NASDAQ:SNY) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel
Why I flew on a tiny helicopter next to a potential nuclear bomb target
Satellite Confirms: Elon Musk Activating Strange 'Dark Energy' Across U.S. South Confirmed by satellites 30...
Altimetry | Sponsoredtc pixel
Elon’s AI supercomputer just went live. Here’s my #1 stock.
Is Elon about to trigger another 315X opportunity? Elon gave Tesla investors the chance to make more than 3...
InvestorPlace | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Is the SpaceX IPO “Rigged?”
The SpaceX IPO filing is official, with 21 banks - including JPMorgan, Goldman Sachs, and Morgan Stanley - pre...
The Oxford Club | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel